Nanobiotix (NBTX) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $71.4 million.

  • Nanobiotix's Total Current Liabilities rose 1724.24% to $71.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $71.4 million, marking a year-over-year increase of 1724.24%. This contributed to the annual value of $63.8 million for FY2024, which is 1823.8% up from last year.
  • Latest data reveals that Nanobiotix reported Total Current Liabilities of $71.4 million as of Q2 2025, which was up 1724.24% from $63.0 million recorded in Q4 2024.
  • Nanobiotix's Total Current Liabilities' 5-year high stood at $71.4 million during Q2 2025, with a 5-year trough of $38.7 million in Q4 2022.
  • Over the past 5 years, Nanobiotix's median Total Current Liabilities value was $54.0 million (recorded in 2023), while the average stood at $54.1 million.
  • In the last 5 years, Nanobiotix's Total Current Liabilities tumbled by 81.38% in 2022 and then skyrocketed by 3864.25% in 2023.
  • Nanobiotix's Total Current Liabilities (Quarter) stood at $45.8 million in 2021, then fell by 15.51% to $38.7 million in 2022, then surged by 38.64% to $53.7 million in 2023, then rose by 17.36% to $63.0 million in 2024, then grew by 13.3% to $71.4 million in 2025.
  • Its Total Current Liabilities was $71.4 million in Q2 2025, compared to $63.0 million in Q4 2024 and $60.9 million in Q2 2024.